• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻男性中央型肺腺癌,酷似肺炎,表现为非复发性多浆膜腔积液且细胞学阴性:病例报告。

Central lung adenocarcinoma in a young male mimicking pneumonia with nonrecurrent polyserous effusions of negative cytology: A case report.

机构信息

Faculty of Medicine, Palestine Polytechnic University, Hebron, State of Palestine.

Faculty of Medicine, Al Quds University, Jerusalem, Palestine.

出版信息

Medicine (Baltimore). 2024 Aug 2;103(31):e39189. doi: 10.1097/MD.0000000000039189.

DOI:10.1097/MD.0000000000039189
PMID:39093786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11296416/
Abstract

INTRODUCTION AND IMPORTANCE

Lung adenocarcinoma may resemble the clinical presentation of an infectious or inflammatory lung disease. The coexistence of lung cancer, and polyserous effusions is uncommon, which may cause a diagnostic challenge. However, any polyserous effusions at a young age must always be suspicious for malignancy.

CASE PRESENTATION

We report a case of 38-year-old male patient with polyserous effusions and pneumonia who was treated accordingly and showed clinical improvement with a significant reduction of pericardial and pleural effusions. Subsequent testing and a biopsy resulted in the histopathological diagnosis of an adenocarcinoma of the lung.

CLINICAL DISCUSSION

Nonrecurrent polyserous effusions in lung adenocarcinoma are uncommon, and negative cytology results may not exclude malignancy due to the moderate sensitivity of pleural and pericardial fluid cytology. Clinicians should remain vigilant for false-negative results, especially in younger patients. Malignancy should not be ruled out because pleural and pericardial fluid cytology have a sensitivity of 60% and 92%, respectively.

CONCLUSION

Our case highlights the diagnostic challenges posed by atypical presentations of lung adenocarcinoma and emphasizes the importance of considering malignancy in the differential diagnosis of polyserous effusions, even when initial cytology results are negative. Clarifying the rationale for this study enhances its relevance and impact.

摘要

介绍和重要性

肺腺癌可能类似于感染或炎症性肺部疾病的临床表现。肺癌和多浆膜腔积液并存并不常见,这可能会导致诊断上的挑战。然而,任何年轻患者的多浆膜腔积液都必须始终怀疑为恶性肿瘤。

病例介绍

我们报告了一例 38 岁男性患者,他患有多浆膜腔积液和肺炎,根据临床表现进行了相应治疗,心包和胸腔积液明显减少,患者的临床症状得到改善。进一步的检查和活检结果为肺腺癌的组织病理学诊断。

临床讨论

非复发性肺腺癌多浆膜腔积液并不常见,由于胸腔和心包积液细胞学检查的中度敏感性,阴性细胞学结果不能排除恶性肿瘤。临床医生应警惕假阴性结果,尤其是在年轻患者中。不能因为胸腔和心包积液细胞学检查的敏感性分别为 60%和 92%而排除恶性肿瘤。

结论

我们的病例强调了肺腺癌不典型表现所带来的诊断挑战,并强调了在多浆膜腔积液的鉴别诊断中即使初始细胞学结果为阴性也要考虑恶性肿瘤的重要性。阐明本研究的基本原理增强了其相关性和影响力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/39a4d4d1e54d/medi-103-e39189-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/e2d1183906d6/medi-103-e39189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/fc271c9d5bd4/medi-103-e39189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/7a794014aa94/medi-103-e39189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/cec4a302d7ed/medi-103-e39189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/1272f2f96f6c/medi-103-e39189-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/38ed212b67f5/medi-103-e39189-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/423ad2372bec/medi-103-e39189-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/fc740f21dace/medi-103-e39189-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/0bbd3c200606/medi-103-e39189-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/39a4d4d1e54d/medi-103-e39189-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/e2d1183906d6/medi-103-e39189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/fc271c9d5bd4/medi-103-e39189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/7a794014aa94/medi-103-e39189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/cec4a302d7ed/medi-103-e39189-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/1272f2f96f6c/medi-103-e39189-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/38ed212b67f5/medi-103-e39189-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/423ad2372bec/medi-103-e39189-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/fc740f21dace/medi-103-e39189-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/0bbd3c200606/medi-103-e39189-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5134/11296416/39a4d4d1e54d/medi-103-e39189-g010.jpg

相似文献

1
Central lung adenocarcinoma in a young male mimicking pneumonia with nonrecurrent polyserous effusions of negative cytology: A case report.年轻男性中央型肺腺癌,酷似肺炎,表现为非复发性多浆膜腔积液且细胞学阴性:病例报告。
Medicine (Baltimore). 2024 Aug 2;103(31):e39189. doi: 10.1097/MD.0000000000039189.
2
A case report of lung adenocarcinoma with polyserous effusions as the onset symptom.以多浆膜腔积液为首发症状的肺腺癌病例报告
Medicine (Baltimore). 2017 Sep;96(36):e7867. doi: 10.1097/MD.0000000000007867.
3
Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.评价心包积液的细胞病理学诊断率:419 例标本的临床病理分析。
Cancer Cytopathol. 2017 Feb;125(2):128-137. doi: 10.1002/cncy.21790. Epub 2016 Oct 24.
4
Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.恶性胸腔积液中胸腔积液细胞学检查的诊断率:澳大利亚一家三级中心的经验
Intern Med J. 2018 Nov;48(11):1318-1324. doi: 10.1111/imj.13991.
5
The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.脱落细胞细胞学检查在渗出性胸腔积液诊断中的价值。
Monaldi Arch Chest Dis. 2018 Sep 11;88(3):944. doi: 10.4081/monaldi.2018.944.
6
Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.肿瘤性积液的细胞形态学特征:一项为期10年的审计,重点关注罕见恶性肿瘤。
J Cancer Res Ther. 2012 Oct-Dec;8(4):602-9. doi: 10.4103/0973-1482.106574.
7
[Thoracocentesis for the assessment of lung cancer with pleural effusion].[胸腔穿刺术用于评估伴有胸腔积液的肺癌]
Arch Bronconeumol. 2002 Oct;38(10):479-84. doi: 10.1016/s0300-2896(02)75269-1.
8
Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution.恶性胸腔积液的诊断和分类:单所学术机构的 6 年回顾。
Diagn Cytopathol. 2021 May;49(5):615-621. doi: 10.1002/dc.24433. Epub 2020 Apr 10.
9
Clinical impact and reliability of carbonic anhydrase XII in the differentiation of malignant and tuberculous pleural effusions.碳酸酐酶XII在鉴别恶性和结核性胸腔积液中的临床影响及可靠性
Asian Pac J Cancer Prev. 2013;14(1):351-4. doi: 10.7314/apjcp.2013.14.1.351.
10
The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.液基细胞学及辅助技术在胸腔积液和心包积液中的作用:一项机构经验。
Cancer Cytopathol. 2015 Apr;123(4):258-66. doi: 10.1002/cncy.21518. Epub 2015 Jan 14.